Characterization of a recombinant pseudorabies virus expressing porcine parvovirus VP2 protein and porcine IL-6. 2020

Hui-Hua Zheng, and Lin-Qing Wang, and Peng-Fei Fu, and Lan-Lan Zheng, and Hong-Ying Chen, and Fang Liu
College of Animal Science and Veterinary Medicine, Henan Agricultural University, Zhengdong New District Longzi Lake#15, 450046, Zhengzhou, Henan Province, People's Republic of China.

Porcine parvovirus (PPV) and pseudorabies virus (PRV) are the important etiological agents of swine infectious diseases, resulting in huge economic losses to the Chinese swine industry. Interleukin-6 (IL-6) has the roles to support host immune response to infections as a pleiotropic cytokine. It is essential to construct a live attenuated vaccine-based recombinant PRV that expresses PPV VP2 protein and porcine IL-6 for prevention and control of PRV and PPV. The recombinant plasmid, pGVP2-IL6, was constructed by porcine IL-6 gene substituting for EGFP gene of the PRV transfer plasmid pGVP2-EGFP containing VP2 gene of PPV. Plasmid pGVP2-IL6 was transfected into swine testicle cells pre-infected with the virus rPRV-VP2-EGFP strain through homologous recombination and plaque purification to generate a recombinant virus rPRV-VP2-IL6. The recombinant PRV was further identified by PCR and DNA sequencing, and the expression of the VP2 protein and porcine IL-6 was analyzed by reverse transcription-PCR (RT-PCR) and Western blot. The virus titer was calculated according to Reed and Muench method. The immunogenicity of the recombinant virus was preliminarily evaluated in mice by intramuscular administration twice with the rPRV-VP2-IL6 at 4-week intervals. A recombinant virus rPRV-VP2-IL6 was successfully constructed and confirmed in this study. The properties of rPRV-VP2-IL6 were similar to the parental virus HB98 in terms of growth curve, morphogenesis and virus plaque sizes, and rPRV-VP2-IL6 was proliferated in different cell types. It induced specific antibodies against PPV as well as a strong increase of PPV-specific lymphocyte proliferation responses in mice immunized with rPRV-VP2-IL6, and provided partial protection against the virulent PPV challenge. rPRV-VP2-IL6 also induced a high level of neutralizing antibodies against PRV, and significantly reduced the mortality rate of (1 of 10) following virulent PRV challenge compared with the control (10 of 10). The recombinant rPRV-VP2-IL6 might be a potential candidate vaccine against PRV and PPV infections in pigs.

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D010322 Parvoviridae Infections Virus infections caused by the PARVOVIRIDAE. Parvovirus Infections,Infections, Parvoviridae,Infections, Parvovirus,Infection, Parvoviridae,Infection, Parvovirus,Parvoviridae Infection,Parvovirus Infection
D011557 Pseudorabies A highly contagious herpesvirus infection affecting the central nervous system of swine, cattle, dogs, cats, rats, and other animals. Aujeszky's Disease,Aujeszky Disease,Aujeszkys Disease
D011558 Herpesvirus 1, Suid A species of VARICELLOVIRUS producing a respiratory infection (PSEUDORABIES) in swine, its natural host. It also produces an usually fatal ENCEPHALOMYELITIS in cattle, sheep, dogs, cats, foxes, and mink. Aujeszky's Disease Virus,Swine Herpesvirus 1,Aujeszky Disease Virus,Herpesvirus 1 (alpha), Suid,Herpesvirus Suis,Pseudorabies Virus,Suid Herpesvirus 1,Aujeszkys Disease Virus,Herpesvirus 1, Swine,Pseudorabies Viruses,Virus, Pseudorabies,Viruses, Pseudorabies
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D000071497 Immunogenicity, Vaccine The capacity of VACCINES to stimulate the ADAPTIVE IMMUNE RESPONSE to produce antibodies and antigen-specific T-CELL responses. It is typically measured in vaccinated individuals in observational studies setting. Antigenicity, Vaccine,Vaccine Antigenicity,Vaccine Immunogenicity
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies

Related Publications

Hui-Hua Zheng, and Lin-Qing Wang, and Peng-Fei Fu, and Lan-Lan Zheng, and Hong-Ying Chen, and Fang Liu
March 2016, Bing du xue bao = Chinese journal of virology,
Hui-Hua Zheng, and Lin-Qing Wang, and Peng-Fei Fu, and Lan-Lan Zheng, and Hong-Ying Chen, and Fang Liu
November 2007, Biotechnology letters,
Hui-Hua Zheng, and Lin-Qing Wang, and Peng-Fei Fu, and Lan-Lan Zheng, and Hong-Ying Chen, and Fang Liu
June 2011, Virology journal,
Hui-Hua Zheng, and Lin-Qing Wang, and Peng-Fei Fu, and Lan-Lan Zheng, and Hong-Ying Chen, and Fang Liu
December 2005, Yi chuan xue bao = Acta genetica Sinica,
Hui-Hua Zheng, and Lin-Qing Wang, and Peng-Fei Fu, and Lan-Lan Zheng, and Hong-Ying Chen, and Fang Liu
September 2009, Bing du xue bao = Chinese journal of virology,
Hui-Hua Zheng, and Lin-Qing Wang, and Peng-Fei Fu, and Lan-Lan Zheng, and Hong-Ying Chen, and Fang Liu
January 2007, Veterinary microbiology,
Hui-Hua Zheng, and Lin-Qing Wang, and Peng-Fei Fu, and Lan-Lan Zheng, and Hong-Ying Chen, and Fang Liu
May 2006, Sheng wu gong cheng xue bao = Chinese journal of biotechnology,
Hui-Hua Zheng, and Lin-Qing Wang, and Peng-Fei Fu, and Lan-Lan Zheng, and Hong-Ying Chen, and Fang Liu
August 2005, Veterinary microbiology,
Hui-Hua Zheng, and Lin-Qing Wang, and Peng-Fei Fu, and Lan-Lan Zheng, and Hong-Ying Chen, and Fang Liu
January 2022, BMC veterinary research,
Hui-Hua Zheng, and Lin-Qing Wang, and Peng-Fei Fu, and Lan-Lan Zheng, and Hong-Ying Chen, and Fang Liu
November 2005, Sheng wu gong cheng xue bao = Chinese journal of biotechnology,
Copied contents to your clipboard!